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Background: The healthy human intestine is represented by the presence of bacterial communities predominantly
belonging to obligate anaerobes; however disparity and dysanaerobiosis in intestinal microflora may lead to the
progression of ulcerative colitis (UC). The foremost aim of this study is to consider and compare the gut microbiota
composition in patients suffering from different stages of UC.
Methods: This study represents data from the biopsy samples of six individuals suffering from UC. The samples
were collected by colonoscopy and were processed immediately for isolation of DNA. Mucosal microbiota was
analyzed by means of 16S rRNA gene-based Illumina high throughput sequencing. Quantitative real-time PCR
(qPCR) was performed to determine total bacterial abundances.
Results: Analysis of 23,927 OTUs demonstrated a significant reduction of bacterial diversity consistently from
phylum to species level (p < 0.05) for individuals suffering from severe stage of UC. Significant increase in abundance of
unusual aerobes and facultative anaerobes, including members from the phylum Proteobacteria (p- = 0.031) was also
observed. A 10 fold increase in the total bacterial count was detected in patients suffering from severe inflammatory
stage (2.98 +/−0.49 E + 09/ml) when compared with patients with moderate (1.03+/−0.29 E + 08/ml) and mild
(1.76 +/−0.34 E + 08/ml) stages of inflammation.
Conclusion: The reduction of bacterial diversity with an increase in the total bacterial count indicates a shift of bacterial
communities which signifies dysbiosis and dysanaerobiosis at the mucosal level for patients suffering from UC.
Keywords: Inflammatory disease, Bacterial community shift, 16S rRNA gene, High through-put sequencing, QIIME analysisIntroduction
Prevalence of Functional Gastrointestinal Disorders (FGID)
in western countries is very high, with Inflammatory Bowel
Disease (IBD) being prevalent throughout North America
and Europe [1]. Crohn’s Disease (CD) and Ulcerative Colitis
(UC) are two separate chronic entities of IBD; both have
common features but can be differentiated due to the
respective nature of inflammation and specific disease* Correspondence: yogesh@nccs.res.in
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unless otherwise stated.locations [1-3]. During active CD, any part of the gastro-
intestinal tract (i.e., from mouth to anus) may get affected
while UC is restricted to the colon and the rectum. When
categorized by microscopic features, UC is restricted only
up to the mucosal or epithelial lining of the gastrointes-
tinal tract, while CD may affect the whole bowel wall and
can cause serious transmural lesions [1,4-7].
IBD is postulated to be associated with industrialized
nations, with very less data being available from developing
countries [1]. Although recent studies have shed light on
the role of commensal bacteria intrinsic to the gastrointes-
tinal tract in the pathogenesis and etiology of IBD [1,7-13]
the peculiar nature of dysbiosis that occurs in thel Ltd. This is an Open Access article distributed under the terms of the Creative
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be expounded [4].
The gut of an infant is sterile at the time of birth
[14-16]. The initial step of colonization in infants
involves colonization by facultative anaerobes such as
Escherichia coli or Enterococci. Gradually, with the
increased number of these facultative anaerobes and as
available oxygen is consumed, a favorable environment
is created for subsequent colonization by obligate
anaerobes such as Bifidobacteria, Bacteroides, and
Clostridia [8]. By the age of four, the human gut
microbiota becomes fully mature. From this age, every
individual develops a unique and complex gut micro-
biota which remains stable throughout adulthood
[2,14,16-19]. These complex microbial communities have
evolved and developed persistently in shaping up the
mucosal immune system during the early phase of life.
Absence of these intestinal microbial communities leads
to defective cell mediated immune response, discontinu-
ous cytokine production, reduction of total mucosal cell
turnover and muscle wall thickness, thereby, giving rise
to various autoimmune diseases [3,8,9,16,20,21].
Some of the recent studies have also indicated the
crucial role of phyla Proteobacteria in the pathogenesis of
UC [22]. Proteobacteria is the largest and most diverse
bacterial phyla with known clinical importance in human
gastrointestinal diseases, and are implicated in luminal
dysbiosis leading to the imbalance between the plausible
pathogenic bacteria and functionally defensive commensal
bacteria [22-24].
From the experiments performed so far on animal
models of IBD, it is apparent that very few signs of inflam-
mation are observed in germ-free animals as compared to
the animals that harbour natural microflora [4,8,11]. Many
comparative studies of gut microbiota of patients with
IBD and non-IBD controls have been directed towards
determination of specific core microbiota or assigning
tentatively a particular group, genus, species or strain
of microorganism to the prognosis of IBD [8,9,13,25].
These studies have clearly marked the imbalance or
dysbiosis in the gut microbiota of patients suffering
from either CD or UC [8-11,25]. In addition, one of the
contemporary study has also proved that the micro-
biota composition in healthy and diseased individuals is
influenced by ethnic and geographical factors [26], thus
it becomes more pertinent to study the microbiota
composition from different geographical and ethnic niches.
Collectively, all these studies confirm the changes which
occur in the gut microbial communities in UC patients
as compared to healthy controls. [8-11,25] However,
these cross-sectional studies in which the disease status
is neglected can lead towards complicated outcome,
very few studies, have considered the role of mucosal
microbiota in relation with the severity of disease [27].Studies which investigate the compositional microbiota
with changes in disease status are currently inadequate.
Therefore, the principal aim of the current study is
to evaluate and compare the differences between the
mucosa associated microbiota of patients manifesting
mild, moderate, and severe stage of UC, as defined by
a Simple Clinical Colitis Activity Index (SCCAI) ≥ 5
and Baron Score for UC [4,12,28-30]. We adapted two
independent techniques to assess and correlate specific
bacterial groups in colonic mucosal biopsy samples
(collected in a manner that precisely maintained the
composition of the microbiota). Amplicon libraries of
16S rRNA genes were generated by Illumina-based deep
sequencing method, which were subsequently used to
demonstrate the differences in taxonomic diversity of
microbial communities in patients suffering from the
three different stages of UC. We also applied quantitative
real-time polymerase chain reaction (qPCR) to quantify
the total bacterial abundance among selected sub-sets
of samples. The present findings demonstrate data from
Indian patients with significant irregularities in the in-
testinal microbiota for the first time. Our study shows a
reduction in the overall diversity of the microbial com-
munity with increasing disease severity. We also find a
concurrent decrease of dominant obligate anaerobes
and an increase in the population of unusual aerobes and
other facultative anaerobes. This typical abnormal condi-
tion may be termed as dysanaerobiosis and could have a
role in exacerbation of UC, and other colonic diseases.
Results
Subject characteristics
The study population represents equal number of males
and females, and their disease status was categorised based
upon the respective SCCAI and Baron scores. Other demo-
graphics characters and body mass index (BMI) were simi-
lar in the three study groups (Table 1). Intestinal mucosal
biopsy samples were initially collected from eleven individ-
uals within a period of sixteen months, but the final num-
ber of samples for the study were reduced to six based on
our stringent inclusion criteria (details in material &
methods section).
Operational taxonomic unit (OTU) analysis: abundance
and prevalence
For obtaining a pattern of total richness of the microbial
communities based on operational taxonomic unit (OTU)
analysis, DNA from the biopsy samples of six individuals
was used as described above (or in M&M). A total of
2,271,930 good quality sequence reads were generated.
Clustering of all reads with a 97% pairwise-identity cut-off
resulted in a total of 23,927 OTUs. All reads with less than
97% similarity with the known organisms in Greengenes
database were not considered for further analysis.
Table 1 Essential characteristic of patients and biopsy tissue at time of sampling
No. Diagnosis Age Sex Biopsy site Inflammation Disease stage SCCAI Score Baron score
SP1 UC 42 M Sigmoid Acute Initial ≥ 2 1
SP2 UC 34 F Rectum Acute Initial ≥ 2 1
SP3 UC 28 M Sigmoid Acute Moderate ≥ 3 2
SP4 UC 41 F Rectum Acute Moderate ≥ 3 2
SP5 UC 47 M Descending Colon Chronic Severe ≥ 5 3
SP6 UC 40 F Descending Colon Chronic Severe ≥ 5 3
UC: Ulcerative Colitis; SCCAI: Simple Clinical Colitis Activity Index scores for ulcerative colitis ≥ 5.
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different bacterial taxonomic levels by using Greengenes
database release (May 2013). Twenty two different bacterial
phyla were identified. The most abundant phylotypes found
in patients with severe stage of UC (sample SP5 and SP6)
belonged to Proteobacteria at phylum level (Figure 1),
followed by Bacteroidetes, while OTUs representing Firmi-
cutes and other phyla were negligible. In patients catego-
rized with moderate or intermediate stage UC (sample SP3
and SP4), no clear trend was observed in the distribution ofFigure 1 Box Plot showing the overall prevalence of phylum Proteob
stages (p-value = 0.031).OTUs, however, the abundance of OTUs was again ob-
served to be higher within the phylum Proteobacteria. The
abundance of phylotypes belonging to Actinobacteria also
increased considerably, while significant reduction of phylo-
types affiliated to Bacteroidetes and Firmicutes was ob-
served. Similarly, samples from the patients that were
characterized with mild stage UC (sample SP1 and SP2)
showed abundance of Bacteroidetes and Firmicutes to be
higher than or equal to that of Proteobacteria and Actino-
bacteria (Figures 2 and 3).acteria in samples from UC patients at three different clinical
Figure 2 Relative abundance of OTUs showing the distribution at taxonomic level of bacterial phyla in UC patients at three different
disease stages. Samples – SP5 & SP6 – Severe stage of UC, SP4 & SP3 – Moderate stage of UC, SP2 & SP1- Mild stage of UC.
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The diversity of mucosa-associated microbiota from the
descending colon, sigmoid colon and rectum biopsy
specimens of patients suffering from three different
stages of UC were compared. Despite a definite degree
of inter-group variation in the microbiota between
patients, the distribution of OTUs showed a significant
association with the severity of disease. A steady decrease
in the proportion of Firmicutes, and a sharp increase in
Proteobacteria (p = 0.031) especially the Gammaproteo-
bacteria (p = 0.042) was clearly observed between mild
and severe stage biopsy samples of UC. The percentage
of Firmicutes was notably high in the UC patients man-
ifesting a mild stage compared to that of a severe stage.
Moreover, a shift in the mucosa associated microbiota
from obligately anaerobic bacterial community to faculta-
tive anaerobes, and a simultaneous increase in the unusual
aerobic bacterial community members is clearly evident
among patients at two different inflammatory stages
(Additional file 1: Table S1).
Of the 162 different types of bacterial families observed
during our analysis, 67 families represented more than
1% for any reference OTU in any given sample andwere considered for further analysis. These 67 bacterial
families were then broadly categorized as belonging to
either obligate anaerobes, facultative anaerobes or aerobic
group of bacteria. According to our analysis, 26 bacterial
families had significant P values < 0.05 (refer Additional
file 1: Table S1), while the remaining 41 families, including
Bacteroidaceae, Clostridiaceae, Prevotellaceae, Ruminococ-
caceae, Peptostreptococcaceae, Bacillaceae, Enterobacteria-
ceae, Pasteurellaceae, Alcaligenaceae, Pseudomonadaceae
and Xanthomonadaceae were represented by higher
number of OTUs, but had P values > 0.05. This differ-
ence could arise due to the variation in the bacterial
diversity observed between individuals within the same
inflammatory stage. The abundance of OTU’s representing
the families Enterobacteriaceae, Pasteurellaceae, Alcaligen-
aceae, Pseudomonadaceae, and Xanthomonadaceae was
observed to be at higher levels in the individuals suffering
from chronic inflammatory stage as compared to the acute
inflammatory stage during UC. (Additional file 2: Table S2).
PCoA analysis
Two dimensional Principal Coordinates Analysis (PCoA)
plots of weighted and unweightedUniFrac distances were
Figure 3 Class-level distribution of OTUs which displays the abundance of Class Gammaproteobacteria over other bacterial classes in
patients suffering from severe stage (SP5 & SP6) of UC as compared to Moderate (SP3 & SP4) and mild disease stage (SP1 & SP2) of UC.
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communities between three different clinical stages of
UC (Figure 4). According to Figure 4A& C individuals
suffering from severe stage of UC show different pattern
of clustering as compared to individuals suffering from
moderate and mild stage of UC, while in Figure 4B & D
no specific clustering pattern is observed for relative
abundance of OTUs for different disease stages. Based
on Weighted Unifrac Figures 4B & D it can be specu-
lated that even though the relative abundance of OTUs
in patients suffering from severe stage of UC are not
similar with each other but are quite different as com-
pared to initial and moderate stages of UC (Figure 4).Quantification of bacterial population
Quantitative PCR (qPCR) analysis of total bacterial count
was performed for all the UC sub-set samples. Our results
showed that the intestinal biopsies of the patients suffering
from severe UC contained more number of bacteria, which
may be from less diverse bacterial communities (Figure 5),whearas the bacterial load for samples with moderate and
mild stage of UC were 10 fold lower compared to severe
stages (Figure 6).
Discussion
Many of the previous studies have compared patients
suffering from UC and healthy controls, and have positively
established that the gut microbiota plays a crucial role in
the maintenance of health, and is vital to disorders such as
UC [11,15,16,31]. These studies have also identified the fact
that in healthy controls, the integral complex community
of intestinal microbiota is predominantly constituted by
members of phyla Firmicutes and Bacteroidetes, while
Actinobacteria, Proteobacteria, Fusobacteria, Verrucomi-
crobia, and Cyanobacteria have also been detected in
humans but only in smaller proportions [8,9,24,32,33].
Other studies have shown differences in microbiota by
comparing the data generated from the patients suffering
with active UC and inactive UC. For example, the loss of
bacterial community belonging to clostridial cluster XIVa
has been associated with development of active UC [34].
Figure 4 Principal Coordinate Analysis (PCoA)of samples calculated with QIIME. (A & C) PCoA Plots based on unweightedUniFrac metrics
for all the samples.PCoA plots explain the total bacterial diversity observed in each sample. (B & D)PCoA Plots based on weighted UniFrac metrics for
all the samples. PCoA plots explain the total bacterial abundance observed in each sample.
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acerbation of UC [35] while another study have shown re-
duction in Firmicutes/Bacteroidetes ratio which was
found to be conjugated with the active UC disease state
[36]. All these previous reports have considered UC
patients without differentiating them on the basis ofdisease severity, which make them susceptible towards
selection bias. Only one recent report has shed some
light on the compositional shift and decreased diversity
of some of the bacterial communities compared with the
changing disease status [27]. Here, Andrea K. Bartram
et al., have grouped the patients with the changing disease
Figure 5 Total species level bacterial richness as observed in patients suffering from mild (SP1 & SP2), moderate (SP3 & SP4) and severe
(SP5 & SP6) stages of ulcerative colitis.
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changes in the bacterial diversity in patients suffering
from IBD within the groups, without using any healthy
controls [27]. Another study have investigated the
colonic microbiota of a single patient with UC (12 year
old girl), and have only compared their findings with
previously available references [37]. In the current
study, we have used biopsy samples (mucosal micro-
biota) of UC patients and classified them on the basis
of disease severity, which may give an insight about the
shift in bacterial community. This study enlightens the
dysbiosis occurring between the mucosal microbiota of
patients suffering from UC with increase in the severity
of the disease.
Although limited by the sample size, to our knowledge
this is the first high-throughput sequencing study that
gives an in-depth view of tentative mucosal associated
microbiota involved with the prognosis of UC in Indian
patients. Our sequencing results suggest an episode of
reduction in bacterial diversity from phylum to species
level. Only one hundred species were detected among
the individuals suffering from a severe stage of UC ascompared to approximately two to three hundred spe-
cies that are observed in individuals manifesting a mild
or moderate stage of UC. This disparity in mucosa asso-
ciated bacterial diversity is clearly indicated by OTU
based two dimensional PCoA plots (Figure 4). Consider-
ing mild stages of UC as disease control, further analysis
indicates a gradual reduction in the phyla Bacteroidetes
and Firmicutes, and an increase in the members of phyla
Proteobacteria with increase in severity of the disease.
Although the bacterial diversity in all the six patients
may have differed, there is certainly a dysbiosis, and a
particular group of bacterial community (especially Pro-
teobacteria) starts dominating as the disesase progresses.
In the patients suffering from mild and moderate stage of
UC, the unstability of bacterial diversity may be due to the
competition of the different bacterial communities to
dominate/establish in a particular niche i.e. the human in-
testine (Figures 2 and 3). Results from qPCR based study
of intestinal biopsies samples demonstrate that the bacter-
ial count in patients suffering from severe stage of UC is
much higher (tenfold) when compared to that of patients
categorized under mild or moderate stage of UC, which
Figure 6 Box Plot showing variation between total bacterial loads in samples from patients at mild (SP1 & SP2), moderate (SP3 & SP4)
and severe (SP5 & SP6) stages of ulcerative colitis.
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bacteria belonging to phyla Proteobacteria would have
outnumbered the other bacterial communities normally
prevalent in mucosa associated gastrointestinal microbiota
(Figure 6).
Similar shifts in composition have been reported by
other investigators using both culture-dependent and
molecular techniques [5,13,26,38,39]. However, none of
the previous studies could confirm a specific bacterial
species or a core group of bacterial community to be
associated with the etiology of IBD.
Results obtained from the current study indicate that a
particular species may not be solely responsible in
pathogenesis of UC they point towards the imbalance or
dysbiosis which is observed in gut microbiota, involving
the depletion of obligate anaerobes and an unusual
increase in facultative anaerobes and a few aerobic spe-
cies (Additional file 3: Table S3). This profound disparity
of the gastrointestinal tract may be responsible in acti-
vation of various reactive oxygen species and a subse-
quent increased oxygen tension in the gastrointestinalenvironment. Therefore, the disparity of the gastrointes-
tinal tract may be considered an important component
in the prognosis of UC.Conclusions
Our data demonstrates a dysbiosis and dysanaerobiosis
in the bacterial community profile of patients suffering
from mild, moderate, and severe stages of Ulcerative
Colitis. The sequencing study signifies the decline in the
bacterial community belonging to the phyla Firmicutes
and Bacteroidetes and an unusual increase in Proteobac-
teria among diseased mucosal intestinal niches, thereby,
suggesting a decrease in the influence of obligate anaer-
obes and an increasing influence of facultative anaerobes
and some aerobic bacterial communities. The clinical
relevance of this study still needs to be addressed as it
is difficult to establish the complex relation between
host and microbes and whether the state of dysan-
aerobiosis in the gastrointestinal tract causes exacer-
bation of UC. Further in-depth investigations comparing
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number of patients with UC can give better insights.
Material and methods
Subject characteristics
All the eleven patients included in this study were selected
from those undergoing colonoscopy from Dr. Parimal
Lawate’s Gastroenterology Clinic, Pune, Maharashtra, India.
A written informed consent was obtained from each pa-
tient, and the study was granted ethical approval by the B.J
Govt Medical and Sasoon General Hospitals Ethical Com-
mittee (Ref No. BJMC/IEC/Pharmac/D0311013-13). Patient
details including age, sex and the site of the colon from
where the biopsies were taken are indicated in Table 1. All
the procedures were carried out after preparing the colon
with two bottles (60 ml) of EXELYTE (Oral buffered saline)
solution mixed with 300 ml of sterile flavored water on the
day of colonoscopy. Patients were kept on liquid diet
(Water, Coconut water, Lemon juice) to avoid excess de-
hydration. Two colonic mucosal biopsy samples from the
same mucosal area of approximately 1 × 2 mm size were
collected from each subject. Each biopsy was collected in
1 ml of sterile phosphate buffer saline solution, and biop-
sies were then weighed and almost immediately processed
for DNA extraction. The extracted DNA was preserved at
−20°C until further experiments were performed.
Special care was taken for selection of patients, and
only those individuals who had not received antibiotics
in the past 90 days prior to sample collection were
selected. Three out of eleven patients had not provided
exact information about intake of any sort of antibiotic
or steroid as medicine and thereby were excluded from
the study. Inclusion criteria comprised of subjects with
an approximate age group between 25 to 45 years of
age with any gender but with the same ethnicity. All
individuals were subjected to a clinical investigation by
a gastrointestinal physician to exclude the diagnosis of
Crohn’s disease, inflammatory bowel syndrome, celiac
disease, food nutrient malabsorptions, or any other intes-
tinal abnormality. Two patients were detected to be suffer-
ing from multiple bowel disorder, thus these two patients
were also excluded from the study. The remaining six UC
patients had active GI symptoms at the time of sample
collection as confirmed by standard clinical, endoscopic,
radiological and histopathological criteria.
A gastrointestinal pathologist assigned scores to all the
biopsy samples for the presence of ulceration, and acute
or chronic inflammation. Simple Clinical Colitis Activity
Index score (SCCAI) and modified Baron Score with a
severity scale ranging from 0–5 was assigned to each sam-
ple, where a score of 5 represented the most severe form
of UC. Scores obtained from both the above mentioned
scaling methods were used for gradation of the severity
value for each biopsy used in the study [12,28,29,40,41].DNA extraction and Illumina library generation
Total DNA was extracted from each biopsy sample using
QIAamp Tissue DNA extraction Kit (Qiagen) according
to the manufacturer’s instructions. Purified DNA samples
were subjected to agarose gel electrophoresis and Nano-
drop (Thermo Scientific) analysis for integrity check and
qualitative verification respectively. For each sample,
250 ng/μl of DNA was extracted and subjected to PCR
on a 9700 thermo cycler (Applied biosystems). The V3
region of the 16S rRNA gene was amplified using 341 F
and 534R primers [42].
Four PCR amplifications were carried out for each
sample, using 50 μl reaction mixtures. Each reaction mix-
ture contained 25 pmol of each primer, a 200 μM concen-
tration of each deoxynucleoside triphosphate (dNTP),
1.5 mM MgCl2, and 1 U.
Phusion Hot Start II High-Fidelity DNA polymerase
(Thermo Scientific). The optimum PCR conditions com-
prised of an initial denaturation step at 95°C for 5 min
followed by 20 cycles of 95°C for 1 min, 50°C for 1 min,
and 72°C for 1 min and ended with an extension step at
72°C for 7 min. The products were then separated from
the primer-dimers by electrophoresis on a 2% agarose
gel. PCR products of the appropriate size were recovered
using a QIAquick gel extraction kit (Qiagen, Mississauga,
Ontario, Canada). For each library, quadruplet PCR prod-
ucts for each biopsy sample with unique identification were
mixed in equal nanograms quantities. The sequencing was
carried out at Xcelris Genomics Labs, Ahmedabad, India.
The library was clonally amplified on a cluster generation
platform using Illumina, version 4, and cluster generation
reagents to attain a target density of approximately 150,000
clusters per tile in a single channel of a flow cell. The result-
ing library was then sequenced on Illumina Hi-Seq 2000
(platform), sequencing reagents, generating paired reads of
125 bases. After sequencing was complete, image analysis,
base calling, and error estimation were performed using
Illumina Analysis Pipeline (version 2.6) [43-45]. All se-
quences were submitted to DDBJ Sequence Read Archive
with accession number as [DDBJ: DRA001221].
Initial quality filtering
Using a custom algorithm PANDAseq [46], paired end
Illumina reads were assembled according to index
sequence. If a mismatch was observed, the paired-end
sequences involved in the assembly were discarded. All
sequences with ambiguous base calls were also discarded.
Bioinformatics analysis
Sequences were assigned to operational taxonomic units
(OTUs) by using a closed reference-based OTU picking
method in QIIME v1.7. Greengenes database available on
May, 2013 was used for OTU picking [43,44]. Sequences
from the study were assigned to a reference sequence
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Sequences that did not have 97% identity to any of the
reference sequences in the Greengenes database were not
assigned to OTUs and thus, not considered further in these
analyses. Classification of sequences was performed in
MOTHUR v1.25. UnweightedUniFrac analysis was per-
formed on tables of OTU counts. UniFrac performs a pair-
wise comparison of all communities in a data set, defining
the overall degree of phylogenetic similarity between any
two communities based on the degree of branch length
they share on a bacterial tree of life [43,45,48]. Since sam-
pling depth can impact UniFrac values, and thus clustering
patterns [43,48] data was normalized to the 197,067 reads
(i.e. the least number of reads in sample SP3) before
performing the PCoA analyses. All analyses were carried
out using QIIME v1.7. [44] Taxa summaries at the all
taxonomic level were performed using the RDP classifier
trained on the May, 2013 Greengenes 97% reference data
set using QIIME v1.7.
Quantitative real-time PCR
Total bacterial quantification for all the six biopsies
samples categorised according to severity index, into
three disease stage’s i.e. severe, moderate, and mild
stage of UC, was performed by Quantitative PCR (qPCR).
Thermo cycler 7300 (Applied Biosystems, Foster City,
CA) was used to perform all the qPCR, in conjunction
with sequence detection system (SDS) version 1.4 qPCR
Software. Each PCR was carried out in a final volume of
20 μl and contained the following: 1 × SYBR green qPCR
Master Mix (Qiagen), 0.5 μM of each primer and 40 ng
of purified colonic mucosal DNA. The thermal cycling
conditions were 50°C for 2 minutes and 95°C for 5 minutes
followed by 40 cycles of denaturing at 95°C for 15 seconds,
primer annealing at 60°C for 30 seconds and DNA
extension at 72°C for 90 seconds. Each plate included
triplicate reactions per DNA sample and the appropriate
set of standards. A 466-bp fragment of the bacterial
16S rRNA gene was amplified using the forward primer
5′ TCCTACGGGAGGCAGCAGT-3′ and the reverse
primer 5′ -GGACTACCAGGGTATCTAATCCTGTT-3′
[49]. Extracted DNA from a pure Bacteroidesfragilis
(CCUG 4856) culture was prepared into a series of
tenfold dilution in RNase-free water and was used as a
positive control in order to make a standard curve. For
each reaction, a threshold of luminescence was determined
and compared to the standard curve. Melting curve analysis
of the PCR products was conducted following each assay
to confirm that the fluorescence signal originated from
specific PCR products and not from primer-dimers or
other artefacts. All qPCR plates included a ‘no template’
negative control for each primer set. The abundances of
each bacterial group in UC patients were expressed as a
‘fold change’ with respect to the other group.Statistical analysis
Statistical analysis was performed in R statistical package
[50]. Good’s coverage, chao index, simpson’s index,
simpson’s reciprocal index, student’s T-test and ANOVA
analyses were performed to check if the differences
observed at the family level were significant or not
(p-value < 0.05). Alpha- and beta-diversity analyses were
performed in QIIME v1.7.
Additional files
Additional file 1: Table S1. Distribution of 26 families (P< 0.05) with
average reference OTUs between two inflammatory stages.
Additional file 2: Table S2. Average OTU Abundance observed at family
level between two inflammatory stages.
Additional file 3: Table S3. Total bacterial count by Real time PCR.
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